osimertinib
astrazeneca
['adaura', 'aura ,(-laura)', 'astrazeneca']
re/ adaura #asco2023 1 - hazard ratio are not risk reduction
2 - relative risk (not relevant here but...) are misleading misleading and technically incorrect to state : "cutting risk of death by 51%" in adaura with examples 
Medicine, Oncology (sarcoma, H&N, CUP), Research = EBM, Epi, Policy #metaresearch @Hopitaux_unige (Geneva, CH), @vkprasadlab (UCSF). No COI. Views mine.